The presence of postganglionic sympathetic denervation is well established in Parkinson's disease (PD). Denervation at cardiac and blood vessel sites may lead to abnormal cardiovascular and hemodynamic responses to exercise. The aim of the present investigation was to examine how heart rate (HR) and hemodynamics are affected by an exercise test in PD patients without orthostatic hypotension. Thirty individuals without orthostatic hypotension, fourteen individuals with PD and sixteen age-matched healthy controls, performed an exercise test on a cycle ergometer. Heart rate, blood pressure, and other hemodynamic variables were measured in a fasted state during supine rest, active standing, exercise, and supine recovery. Peak HR and percent of age-predicted maximum HR (HR max) achieved were significantly blunted in PD (p<.05, p<.01). HR remained significantly elevated in PD during recovery compared to controls (p=.03, p<.05). Systolic, diastolic, and mean arterial pressures were significantly lower at multiple time-points during active standing in PD compared to controls. Systemic vascular resistance (SVRI) decreased significantly at the onset of exercise in PD, and remained significantly lower during exercise and the first minute of supine recovery. End diastolic volume (EDVI) was significantly lower in PD during supine rest and recovery. Our results indicate for the first time that normal hemodynamics are disrupted during orthostatic stress and exercise in PD. Despite significant differences in EDVI at rest and during recovery, and SVRI during exercise, cardiac index was unaffected. Our finding of significantly blunted HR max and HR recovery in PD patients has substantial implications for exercise prescription and recovery guidelines.
Parkinson's disease (PD) is a progressive neurodegenerative disorder that has long been characterized by the presence of motor symptoms, first described by James Parkinson in the 19 th century (Parkinson 2002) . Classic motor symptoms include bradykinesia, muscular rigidity, and postural and gait impairment (Gibb and Lees 1988) . These symptoms are associated with loss of dopaminergic neurons and intracytoplasmic inclusions in surviving substantia nigra pars compacta neurons. Although movement abnormalities remain central to the diagnosis of PD, non-motor features are increasingly more accepted.
Autonomic dysfunction has been extensively reported in PD, with the major clinical manifestations being disruption of normal hemodynamics at rest, and during standing and exercise (Jellinger 1990 , Kim et al. 2014 . Furthermore, cardiovascular dysautonomia, has been identified as a premotor feature in multiple types of PD, which worsens with disease progression (Kim et al. 2014) . A retrospective cohort study reported that peak heart rate (HR), percentage of age-predicted maximum HR (HR max ) achieved, and peak blood pressure (BP) were significantly lower during a cardiac stress test in individuals later diagnosed with PD compared to those who remained unaffected by the disease (Palma et al. 2013) . Moreover, Perez et al. (2015) , provided evidence that sympathetic denervation may affect the heart and the vascular system simultaneously. Researchers have begun to detail the mechanisms and physiological consequences of cardiovascular dysautonomia in PD (Barbic et al. 2007 , Kim et al. 2014 ; however, few have attempted to identify the presence of cardiovascular abnormalities before, during, and after an exercise stress test. Though limited, the majority of findings indicate that peak BP and HR during exercise appear blunted in PD patients compared to healthy individuals (DiFrancisco-Donoghue et al. 2009 , Kanegusuku et al. 2016 , Reuter et al. 1999 . Determining D r a f t 4 the mechanisms by which these factors are affected during exercise by examining the hemodynamic variables that regulate each may provide a critical missing link for researchers seeking targets for the diagnosis and treatment of PD. Therefore, the purpose of this study was to identify measures of cardiac and systemic vascular regulation responsible for abnormal BP and HR responses seen in PD patients. We hypothesized that peak systolic blood pressure (SBP) and HR would be significantly lower in PD patients. Additionally, we hypothesized that heart rate recovery (HRR) would be blunted in PD patients, and that systemic vascular resistance index (SVRI) would significantly decrease upon active standing in PD when compared to healthy individuals and remain significantly lower during exercise.
METHODS
Fourteen individuals with PD (68±12 yrs; Hoehn and Yahr stage 1-3) and 16 healthy controls (66±7 yrs) completed the study. Participants were recruited from local communities using flyers, internal databases and through referrals by the School of Medicine's Division of Parkinson's Disease and Movement Disorders. The inclusion criteria were that volunteers be between 45 and 85 years of age, be diagnosed as Stage 1, 2, or 3 on the Hoehn and Yahr scale for PD, or be a healthy individual with no unresolved disease. Participants were excluded if they had been advised by their physician not to exercise; had participated within the past 3 months in an exercise program incorporating vigorous exercise 3 or more days per week; were prescribed any medications that could affect cardiovascular measures; were diagnosed with orthostatic hypotension or displayed symptoms of orthostatic hypotension during the active standing phase of the stress test; had additional neurological disorders which might mask or confound symptoms typically present in PD; or, were unable to provide informed consent. All forms, questionnaires, D r a f t and protocols were approved by the University's Institutional Review Board and all participants signed an informed consent prior to participation.
The study timeline is presented in Figure 1 . On day 1, participants completed all necessary forms and received detailed information regarding the study including testing equipment, test protocols, and potential risks and benefits associated with the testing. To assess eligibility criteria in regard to each participant's current exercise routine, and to collect information on overall participation in physical activity, the Global Physical Activity Questionnaire (GPAQ) was administer face-to-face during the first meeting. The GPAQ was developed by the World Health Organization and uses a standardized protocol for the surveillance of physical activity in countries across the world (Armstrong and Bull 2006) . Information on participation in three domains of physical activity, as well as sedentary behavior is collected. A Hoehn and Yahr stage assessment was also performed.
All participants underwent a symptom-limited, sub-maximal exercise test. Participants arrived at the laboratory between 6-10 am following a 12-hour fast. Patients were asked to fast to avoid any confounding effects of post-prandial hypotension, which has been associated with PD.
Patients were instructed to arrive in the "on" state, meaning that all parkinsonian medications were taken prior to arriving. They were asked to take their usual medications no later than 45-60 minutes before testing to ensure adequate response time. The testing session lasted approximately 1 hour and incorporated 4 stages: resting, active standing, exercise testing, and recovery.
Upon arrival at the laboratory, body weight was measured using a medical dual-beam scale (Detecto Corp, Webb City, MO., USA), which also included a stadiometer to measure height.
Body surface area (BSA) was determined using the Mosteller formula (Mosteller 1987) stood quietly for 5 minutes to assess orthostatic tolerance (active standing phase). To assess orthostatic hypotension, the following criteria were used: a sustained reduction of systolic blood pressure of at least 20 mmHg or diastolic blood pressure of 10 mmHg, or both, within 3 min of standing (Freeman et al. 2011) . If these criteria were met, participants were not allowed to complete the remainder of the study, and all data was removed from the database. The effects of orthostatic hypotension on blood pressure response during orthostatic stress and exercise are well documented and could significantly alter the study's findings (Asahina et al. 2012 , Low et al. 2013 , Smith et al. 1995 . Moreover, as described by Vianna et al. (2016) , PD patients with OH may also have altered HR responses to orthostatic stress. Therefore, these individuals were excluded in an effort to ensure that any observed differences in BP are due to PD pathology, and not a result of orthostatic hypotension. 
Statistical Analysis
Descriptive statistics were calculated to provide participants' characteristics. Additionally, all data collected from the GPAQ were cleaned and analyzed using coding provided by EpiInfo, based on guidelines established by the World Health Organization. A repeated-measures ANOVA was used to examine significant within-and between-group differences for all hemodynamic measures. Bonferroni post hoc analyses were used to assess pairwise differences.
All significance tests were two-tailed with a significance level of p < .05 set a priori. Effects sizes were assessed using Hedge's g with 0.80 considered large, 0.50 considered medium, and 0.20 considered small. A power analysis using a minimum power of 0.80 with an alpha level set at 0.05, yielded a sample size of 14 participants per group. All analyses were performed using SPSS, version 24 statistical package (IBM SPSS Statistics, Armonk, NY).
RESULTS
Thirty participants were included in the analysis: 16 healthy controls (CON) and 14 PD patients.
Baseline characteristics are shown in Table 1 . PD patients weighed significantly less at baseline than their age-matched counterparts (MD (mean difference)=-13.6, p=.01); therefore, index values (relative to body surface area) were calculated for all hemodynamic measures. No significant between-group differences were detected in rating of perceived exertion at peak exercise (CON=15.0 ± 2.0; PD=16.1 ± 2.4). Table 2 provides the percentage of participants from each group who completed each corresponding stage of the exercise test.
Heart Rate Responses to Active Standing
Results for HR and HR max are displayed in Table 3 . HR significantly increased from baseline for all time-points in the PD group during active standing, while significant increases were first noted at 5 minutes for CON. There was a significant between-group difference for HR at 1-minute of active standing with a higher HR for PD than CON (MD=6.5, p=.03, g=0.80) .
Heart Rate Responses during Exercise and Recovery
Peak HR during exercise was significantly higher in the CON group (MD=9.7, p=.03, g=0.80 remaining time-points. There were no significant between-group differences at any time-points.
DISCUSSION
The principal findings of this study were that participants with PD had lower HR at peak exercise, diminished BP response to active standing, and altered hemodynamic responses at rest, during exercise, and in recovery. Additionally, it appears that strategies for maintaining perfusion during orthostatic stress may be different in PD compared to CON.
Expectedly, values for peak HR and percentage of HR max achieved were blunted for PD compared to CON. These findings are in agreement with several previous studies revealing that on average, PD patients are only able to achieve 75-85% of their HR max ; this finding appears to occur independent of testing modality [DiFrancisco-Donoghue et al. 2009 , Kanegusuku et al. 2016 , Palma et al. 2013 , Speelman et al. 2012 , Werner et al. 2006 ). Numerous studies in PD patients have reported autonomic imbalances that may directly underlie abnormalities in HR (Orimo et al. 2007 , Shibata et al. 2009 , though a definitive relationship has yet to be established.
The predominant theory suggests that impaired ability to increase HR in PD patients, to a similar extent as healthy individuals at peak exercise, is due primarily to cardiac sympathetic denervation (Nakamura et al. 2010 , Shibata et al. 2009 , and that sympathetic denervation can begin early in the disease process (Orimo et al. 2007 , Strano et al. 2016 ). with some studies demonstrating no difference in BP between PD and control groups during exercise (Nakamura et al. 2010 , Werner et al. 2006 , while others reported significant differences at both sub-maximal and maximal intensities (Kanegusuku et al. 2016 , Reuter et al. 1999 ).
Nonetheless, there is consensus among researchers that BP responses of PD patients are blunted at peak exercise intensities. In contrast to our hypothesis, there were no significant betweengroup differences in SBP or MAP at peak exercise, although large mean differences were apparent. This finding, while not significant, is in agreement with results reported by Kanegusuku et al. (2016) , which revealed lower SBP values in PD patients compared to CON at sub-maximal and peak intensities.
This study was the first to our knowledge to assess measures of cardiac response, systemic blood flow, and SVRI during exercise in PD patients. Although there are no normative data for these measures in persons with PD, age-specific norms do exist for healthy individuals (Cain et During exercise, changes in SVI and CI were comparable to those of other studies using treadmills and cycling (Mile et al. 1984 , Thadani and Parker 1978 , Vella et al. 2011 ). It should be noted, however, that these studies included predominately younger subjects. Mean values for SVRI at rest were higher for both groups than those reported in a younger population (Connes et al. 2012 ), but were comparable to reported values for an age-matched healthy population at rest and peak exercise (Maeder et al. 2010 ). This finding is not unexpected, as SVRI generally increases with age (Amery et al. 1978 ). An important and previously unreported finding is that PD patients had a significantly steeper decline in SVRI at the onset of exercise compared to (Hakusui et al. 1994) , which would theoretically limit sympathetic-induced increases in contractility and SVI. However, a study by Perez et al. (2015) , indicates that in the absence of orthostatic hypotension, the degree of denervation does not produce any effect on inotropic function. Preload, as reflected by EDVI, was lower in PD; therefore, reduced afterload may have allowed for SVI compensation.
Study Limitations
We acknowledge several limitations of the present study. There was not an assessment to examine the degree of cardiac sympathetic denervation for each participant. Individuals with greater denervation may have a greater reduction in cardiac contractility, although this has not been conclusively established. In an effort to study a more general population of PD patients, this study included patients with a variety of parkinsonian medications and doses; therefore, responses may have been altered as a result of medication. However, previous studies reported no effect of parkinsonian medication on cardiovascular responses (DiFranciso-Donoghue et al. 2009 , Goldstein et al. 2005 . Due to the nature of our measurements, it was appropriate to exclude individuals prescribed any cardiovascular medication. This reduced the generalizability of our findings and does not adequately address expected responses for healthy individuals or PD patients with hypertension or other cardiovascular disease. Differences in cardiocirculatory regulation have been noted in men and women, although some have reported that this effect diminishes with aging (Kuo et al. 1999 , Reckelhoff 2001 . Nonetheless, the imbalance in each group may have affected some outcome measures. Results are limited to sub-maximal tests performed on a cycle ergometer and may be different than those performed at a maximum intensity or using a different exercise modality; however, sub-maximal tests are more common in D r a f t clinical practice, thus we feel the use of this test was warranted given the similarity of previous results between sub-maximal and maximal protocols and the lesser degree of risk imposed on PD patients. Finally, total calculated physical activity was greater in CON compared to PD patients.
While some participants were excluded based on their reported exercise routine, we could not entirely account for this difference between groups. Thus, training status may have affected some outcome measures. Although we do acknowledge this limitation, no previous study has attempted to quantify the physical activity of their participants, and many simply did not report training status (DiFranciso-Donoghue et al. 2009 , Nakamura et al. 2010 , Reuter et al. 1999 ).
Moreover, others required recent exercise experience with the testing modality (Werner et al.
2006)), or reported that those undergoing physiotherapy were allowed in the study (Kanegusuku et al. 2016 ). Based on this and the similarity of our findings regarding HR and BP with the majority of previous studies, it is likely that our results reflect the pathophysiological manifestations of PD and not differences in activity levels.
Conclusions
Measures of BP were lower for PD patients at rest, as were HR and SVRI responses at the onset of exercise. HR response was also blunted in PD patients at peak exercise and in recovery, when compared to healthy controls. Our finding that PD patients were largely unable to reach their age-predicted target HR implies that their capacity to conduct high-intensity exercise using predicted values may be limited. Future research is needed using stress echocardiography or more invasive techniques to determine how cardiac function and peripheral blood flow are affected in PD. Cardiovascular dysautonomia is present in many PD patients, even in the premotor stage, and identification of changes in hemodynamics may offer additional biomarkers for the early diagnosis of PD and aid in assessing the progression of disease severity. Disorders, and our undergraduate students for their continued dedication and help.
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